文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

LncDNAH5通过MDM2介导的TP53BP1降解调控放疗毒性

LncDNAH5 Regulates Radiation Therapy-Induced Toxicity via MDM2-Mediated Degradation of TP53BP1.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2026-08-01

该研究探讨rs7720298变异通过长链非编码RNA LncDNAH5调控TP53BP1降解,影响DNA修复途径选择,进而介导前列腺癌放疗后晚期泌尿毒性。小鼠膀胱特异性过表达LncDNAH5加重辐射诱导的炎症和纤维化反应。LncDNAH5表达水平和rs7720298基因分型可能作为晚期泌尿毒性的预测生物标志物。

要点

  • rs7720298变异通过调控LncDNAH5表达影响放疗诱导的毒性。
  • LncDNAH5下调TP53BP1,抑制NHEJ并促进HR。
  • LncDNAH5过表达加重小鼠辐射诱导的炎症和纤维化。

核心结论

  • rs7720298变异可通过调控LncDNAH5表达影响放疗诱导的毒性。
  • LncDNAH5表达水平和rs7720298基因分型可能作为晚期泌尿毒性的预测生物标志物。

研究设计与样本

  • 通过生物信息学分析鉴定靠近rs7720298位点的长链非编码RNA LncDNAH5。
  • 使用人类组织和细胞系检查LncDNAH5表达及rs7720298等位变异的功能影响。
  • 采用膀胱特异性过表达LncDNAH5的小鼠模型评估其在辐射诱导毒性中的作用。

主要发现

  • LncDNAH5通过下调TP53BP1调控DNA修复途径选择,抑制非同源末端连接(NHEJ)并促进同源重组(HR)。
  • LncDNAH5可能通过促进MDM2与TP53BP1物理复合物形成,增强MDM2介导的TP53BP1泛素化和降解。
  • Nutlin-3处理可减弱上述效应。
  • 小鼠膀胱特异性过表达LncDNAH5加重辐射诱导的炎症和纤维化反应。

关键数值与推荐

  • rs7720298位于DNAH5基因内含子30,与放疗后2年相比基线尿流减少的晚期泌尿毒性显著相关。

临床怎么用

  • LncDNAH5表达水平和rs7720298基因分型可能用于预测前列腺癌患者放疗后晚期泌尿毒性,促进早期干预和个性化辐射防护策略。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Radiation therapy (RT) is a primary curative treatment for prostate cancer, but its biophysical effects are not cancer cell-specific, often leading to toxicity in adjacent tissues. Genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) associated with RT-induced toxicities. Specifically, rs7720298, located in intron 30 of the DNAH5 gene, is significantly linked to late urinary toxicity, notably a reduced urinary stream two years post RT compared to baseline. However, the molecular and cellular mechanisms underlying this association remain unclear. METHODS AND MATERIALS: Through bioinformatics analysis, we identified LncDNAH5, a long non-coding RNA close to the rs7720298 locus that regulates its expression. Using human tissues and cell lines, we examined LncDNAH5 expression and the functional impact of rs7720298 allelic variation. A mouse models with bladder-specific overexpression of LncDNAH5 was employed to evaluate its role in radiation-induced toxicity. RESULTS: LncDNAH5 regulates DNA repair pathway choice by downregulating TP53BP1, thereby suppressing non-homologous end joining (NHEJ) and promoting homologous recombination (HR). It does so likely through enhancing MDM2-mediated ubiquitination and degradation of TP53BP1 by promoting physical complex formation between these two proteins. These effects were attenuated by Nutlin-3 treatment. Bladder-specific overexpression of LncDNAH5 in the mouse exacerbated radiation-induced inflammatory and fibrotic responses. CONCLUSIONS: The rs7720298 variant can influence RT-induced toxicity via regulation of LncDNAH5 expression. Both LncDNAH5 expression levels and rs7720298 genotyping may serve as predictive biomarkers for late urinary toxicity, facilitating early intervention and personalized radioprotective strategies to improve outcomes in prostate cancer patients.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Sun X, Dong A, Li L, et al. LncDNAH5 Regulates Radiation Therapy-Induced Toxicity via MDM2-Mediated Degradation of TP53BP1. Int J Radiat Oncol Biol Phys. 2026. PMID: 42542301. doi:10.1016/j.ijrobp.2026.07.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。